Additionally, ALDH2*2 is reported to increase the risk for leprosy [9], whereas viral hepatitis is mild in ALDH2*2 carriers [10], likely due to the alleviation of inflammation by the presence of aldehydes [11, 12]. This evidence concerns the gene ALDH2 and viral hepatitis.